Iovance Biotherapeutics aims to be the global leader in innovating, developing and delivering tumor infiltrating lymphocyte (TIL) therapy for people with cancer. We are pioneering a transformational approach to treating cancer by harnessing the ability of the human immune system to recognize and attack diverse cancer cells in each patient. The Iovance TIL platform has demonstrated promising clinical data across multiple solid tumors. We are committed to continuous innovation in cell therapy, including gene-edited cell therapy, which may be a promising option for patients with cancer. Overview The Executive Director, Regulatory Affairs is responsible for overseeing the global regulatory clinical strategy development and execution of the regulatory affairs objectives. The Executive Director oversees the development of clinical regulatory strategies for earliest possible approvals of the company’s regulatory applications at all stages of development (e.g., phase 1 through phase 4 and post launch). The Executive Director, Regulatory Affairs is responsible for tracking trends and requirements in the global market, and the impact that the changes will have on the company’s product portfolio. Addresses the analysis and evaluation of regulatory procedures and changes on the company’s products to ensure attainment of financial and strategic goals. Identifies and recommends the most effective path to regulatory approval to bring the company’s products to market in a cost-effective, compliant manner. This position oversees the evaluation and analysis of the impact of trends relative to government regulatory activities on a global basis.
Stand Out From the Crowd
Upload your resume and get instant feedback on how well it matches this job.
Job Type
Full-time
Career Level
Executive
Number of Employees
251-500 employees